BBRR.F Stock Overview
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Blueberries Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.012 |
| 52 Week High | CA$0.03 |
| 52 Week Low | CA$0.0054 |
| Beta | 1.99 |
| 11 Month Change | -27.27% |
| 3 Month Change | 5.73% |
| 1 Year Change | -1.32% |
| 33 Year Change | -78.18% |
| 5 Year Change | -86.33% |
| Change since IPO | -95.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| BBRR.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -1.6% | -1.4% | 0.3% |
| 1Y | -1.3% | 10.8% | 31.1% |
Return vs Industry: BBRR.F underperformed the US Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: BBRR.F underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| BBRR.F volatility | |
|---|---|
| BBRR.F Average Weekly Movement | 30.9% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BBRR.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BBRR.F's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Facundo Garreton | blueberriesmed.com |
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.
Blueberries Medical Corp. Fundamentals Summary
| BBRR.F fundamental statistics | |
|---|---|
| Market cap | US$4.29m |
| Earnings (TTM) | -US$922.06k |
| Revenue (TTM) | US$206.39k |
20.8x
P/S Ratio-4.6x
P/E RatioIs BBRR.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BBRR.F income statement (TTM) | |
|---|---|
| Revenue | CA$288.29k |
| Cost of Revenue | CA$186.37k |
| Gross Profit | CA$101.92k |
| Other Expenses | CA$1.39m |
| Earnings | -CA$1.29m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0032 |
| Gross Margin | 35.35% |
| Net Profit Margin | -446.76% |
| Debt/Equity Ratio | 0% |
How did BBRR.F perform over the long term?
See historical performance and comparison